Abstract
The current general approach to the development of a level A in vivo-in vitro correlation (IVIVC) is open to criticism in two major respects. The statistical methodology used is not based on the statistical properties of the data being analysed and consequently parameter estimates may be biased and the analysis may be inefficient. The second criticism is that a linear model is used and this is clearly very restrictive and limits the number of instances where we might expect to find such a relationship. This chapter addresses both of these issues. New statistical methods for the current linear model are proposed and their effectiveness demonstrated by means of a simulation experiment. In addition, new non-linear models which are generalisations of the linear model are proposed together with appropriate statistical methodology for fitting them. These models are shown to have some promise by using them to describe the in vivo-in vitro relationship for a number of batches of an extended release drug product.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gibaldi, M. and Perrier, D. (1982) Pharmacokinetics. Marcel Dekker, New York.
Dietrich, R., Brausse, R., Benedikt, G. and Steinijans, V.W. (1988) Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation. Arzneim. Forsch. Drug Res., 38, 1229–1237.
Hussein, Z. and Friedman, M. (1990) Release and absorption characteristics of novel theophylline sustained-release formulations: In vitro-in vivo correlation. Pharm Res., 7, 1167–1171.
Mojaverian, R, Radwanski, E., Lin, C.C., Cho, P., Vadino, W.A. and Rosen, J.M. (1992) Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations. Pharm. Res., 9, 450–456.
Humbert, H., Cabiac, M.D. and Bosshardt, H. (1994) In vitro-in vivo correlation of a modified-release oral form of ketotifen: In vitro dissolution rate specification. J. Pharm. Sci., 83, 131–136.
Hwang, S.S., Gorsline, J., Louie, J., Dye, D., Guinta, D. and Hamel, L. (1995) In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product. J. Clin. Pharmacol., 35, 259–267.
Polli, J.E., Crison, J.R. and Amidon, G.L. (1996) Novel approach to the analysis of in vitro-in vivo relationships. J. Pharm. Sci., 85, 753–759.
Leeson, L.J. (1995) In vitro/in vivo correlations. Drug Information Journal, 29, 903–915.
Snedecor, G.W. and Cochran, W.G. (1989) Statistical Methods. Iowa State University Press, Ames, Iowa.
USP (1988) In-vitro/in-vivo correlation for extended-release oral dosage forms. Pharmacopeial Forum, 14, 4160–4161.
Morrison, D.F. (1978) Multivariate Statistical Methods, McGraw-Hill, Singapore.
Crowder, M.J. and Hand, D.J. (1990) Analysis of Repeated Measures. Chapman and Hall, London.
Searle, S.R., Casella, G. and McCulloch, CE. (1992) Variance Components. Wiley, New York.
Wolfinger, R. and O’Connell, M. (1993) Generalized linear mixed models: a pseudo-likelihood approach. J. Statist. Comput. Simul. 48, 233–243.
Gillespie, W.R. (1992) PCDCON: Deconvolution for Pharmacokinetic Applications. Documentation for PCDCON computer program, University of Texas at Austin.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Plenum Press, New York
About this chapter
Cite this chapter
Dunne, A., O’Hara, T., Devane, J. (1997). Approaches to IVIVR Modelling and Statistical Analysis. In: Young, D., Devane, J.G., Butler, J. (eds) In Vitro-in Vivo Correlations. Advances in Experimental Medicine and Biology, vol 423. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6036-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6036-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-6038-4
Online ISBN: 978-1-4684-6036-0
eBook Packages: Springer Book Archive